NDSIB
ROIV icon

North Dakota State Investment Board’s Roivant Sciences ROIV Stock Holding History

North Dakota State Investment Board’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
12,628
+1,231
+11% +$36.4K 0.02% 528
2026
Q1 		$316K Sell
11,397
-2,205
-16% -$56.6K 0.01% 612
2025
Q4 		$295K Buy
+13,602
New +$268K 0.01% 686

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

North Dakota State Investment Board's ROIV Position: Q2 2026 in Review

North Dakota State Investment Board increased its Roivant Sciences (ROIV) stake by 11% in Q2 2026, buying an estimated $36.4K and bringing the position to 12,628 shares worth $447K. The position accounts for 0.02% of the portfolio, ranked #528.

North Dakota State Investment Board first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • North Dakota State Investment Board held 12,628 shares of Roivant Sciences worth $447K as of Q2 2026.
  • North Dakota State Investment Board bought 1,231 Roivant Sciences shares in Q2 2026, an estimated $36.4K.
  • Roivant Sciences made up 0.02% of North Dakota State Investment Board's portfolio in Q2 2026, its #528 holding.
  • North Dakota State Investment Board first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.